Press Releases

Avicanna´s Majority Owned Colombian Subsidiary Attains 2021 THC Production Quota and Completes First Commercial Export of Aureus™ Branded THC Active Pharmaceutical Ingredients to Chile – March 29,2021
Avicanna to Participate in Benzinga Biotech Small Cap Conference and the Virtual Life Sciences Investor Forum both taking place on Thursday March 25th – March 25, 2021
Avicanna Enters Multi-level Strategic Partnership with Al Harrington’s, Harrington Wellness Inc., to Commercialize re+PLAY™ Branded Products in Canada and the United States – February 9, 2021
Avicanna Launches RHO Phyto™ Topical Gels in Canada and Initiates Clinical Studies – January 28, 2021
Avicanna Initiates Pre-Clinical and Behavioural Studies on its RHO Phyto™ Formulary with University of Guelph and Provides Research and Management Team Updates – January 21, 2021
Avicanna Advances Pharmaceutical Epilepsy Program with Collaboration with The University Health Network and GMP Manufacturing Of Its First Pharmaceutical Preparation – January 6, 2021
Avicanna Announces Exercise And Closing Of Over-Allotment Option – December 31, 2020
Avicanna To Expand Access To Its Advanced And Evidence-based Rho Phyto Medical Products Through Provincial Retailers Across Canada – December 23, 2020
Avicanna Expands Distribution Network In South America Through Commercial Partnerships In Ecuador And Commercial Export Of Feminized Seeds To Uruguay – December 17, 2020
Avicanna Launches Medical Cannabis Program With Its Rho Phyto™ Formulary Nationwide In Colombia – December 10, 2020
Avicanna Announces Closing of Public Offering of Units – December 8, 2020
Avicanna Announces Overnight Marketed Public Offering of Units – November 12, 2020
Avicanna Reports Third Quarter 2020 Financial Results and Provides Corporate Update – November 12, 2020
Avicanna Enters Agreement to Develop and License Cannabinoid Tablet Formulations for US Distributor Partner – September 29, 2020
Avicanna’s Subsidiary Obtains GPP Certification and Authorization By INVIMA For The Compounding and Sale Of Pharmaceutical Cannabinoid Products With Medical Prescriptions In Colombia – September 14, 2020
Avicanna Advances its Supply Chain Business with Commercial Exports of CBG And CBD into the United States and Germany as well as Industrial Scale THC Quota Granted by the Colombian Authorities – August 24, 2020
Avicanna Closes Non-Brokered Private Placement Raising $2.7 Million – August 18, 2020
Avicanna’s RHO Phyto™ Medical Product Line is Now Available Nation-Wide in Canada Through Medical Cannabis by Shoppers Inc. – August 12, 2020
Avicanna and Red White & Bloom enter Exclusive Partnership for the Distribution and Commercialization of Pura H&W Hemp-Derived CBD-Based Topical Products in the United States – August 11, 2020
Avicanna announces the award of two Canadian government NSERC grants: 1) Cannabinoid-based pharmaceutical formulations for the treatment of COVID-19 in collaboration with the University of Toronto; and, 2) Evaluation of cannabinoids for reversing cannabis-based toxicosis in collaboration with the University of Guelph – July 24, 2020
Avicanna Announces Participation in a Medical Cannabis Real-World Evidence (MC-RWE) Clinical Study Led by the University Health Network in Partnership with Medical Cannabis by Shoppers™ Inc. using its Rho Phyto™ Advanced Medical Cannabis Formulary of Products – July 15, 2020
Avicanna Announces Co-development of a Cannabinoid-based Formulation for Treatment of COVID-19 related Lung Inflammation with Support from the Mitacs Accelerate Program – June 23, 2020
Avicanna to Host Virtual Symposium Titled “Medical Cannabis 2.0” on July 21st, 2020 in Partnership with Medical Cannabis By Shoppers™ in Anticipation of the Launch of its Rho Phyto™ Product Line – June 22, 2020
Avicanna Completes First Ever Export of Feminized Hemp Seeds For Cultivation Use to the United States and Closes the Initial Sale – June 18, 2020
Avicanna Successfully Registers the First Group of its Pura Earth™ CBD-Based Derma-Cosmetic Product Line in the European Union in Preparation for its Commercialization – June 9, 2020
Avicanna Signs Wide-Ranging Strategic Manufacturing and IP Licensing Agreement with World-Class Canadian Manufacturer MediPharm Labs – May 14, 2020
Avicanna Receives Government Support and Approval for First Ever Export of Hemp Seeds From Colombia – May 7, 2020
Avicanna Closes Non-Brokered Private Placement with Group of Strategic Investors and Announces Warrant Re-Pricing – April 21, 2020
Avicanna to Supply Australian Market with Cannabis-Based Medicinal Products Through Distribution Agreement with Cannvalate – February 24, 2020
Avicanna Ranks Highest Amongst Global Cannabis Companies in the SAM Corporate Sustainability Assessment (CSA) – February 6, 2020
Avicanna Closes First Tranche of Private Placement – January 26, 2020
Avicanna Announces Appointment of Benjamin Leavenworth as Independent Director – January 21, 2020
Avicanna Announces the Successful Completion of its Clinical Study Evaluating the Effect of an Emollient Cream Containing 0.5% Cannabidiol on Skin Hydrationr – January 13, 2020
Avicanna Announces Agreement with Medical Cannabis by Shoppers, a Subsidiary of Shoppers Drug Mart Inc., to Distribute Avicanna’s Advanced and Evidence-based Medical Cannabis and Derma-Cosmetic Products Across Canada – January 10, 2020
Avicanna Enters Into USD$5 Million Revolving Credit Facility – December 27, 2019
Avicanna Receives DTC Eligibility for Common Shares on OTCQX – December 5, 2019
Avicanna to Supply UK Market with Cannabis-Based Medicinal Products Through Distribution Agreement with the LYPHE Group – December 3, 2019
Avicanna’s Rho Phyto Branded Products to be Available in California – December 1, 2019


480 University Ave, Suite 1502
Toronto, ON M5G 1V2

Want to stay up to date? Subscribe to receive email updates.

© 2017-2019 Avicanna Inc. All Rights Reserved.

Sign up and join our Newsletter  

Stay updated with all latest
updates and news.